Wave Life Sciences Ltd.: PRISM Platform and Progress in the [Potential Treatment] of Obesity Impress Analysts!
Reading Time: 4 minutes
Wave Life Sciences Ltd. (WVE) is a clinical-stage biopharmaceutical company focused on the development of precision medicines based on RNA technologies. The company leverages its expertise in oligonucleotide chemistry and its proprietary PRISM platform to develop therapies for rare genetic diseases as well as common conditions like obesity. Unlike traditional small-molecule or antibody therapies, Wave's solutions aim to correct, edit, or silence disease-causing genetic information at the ribonucleic acid (RNA) level. This enables a highly specific...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
